Replies to post #5537 on Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

The PPS is hovering near 52-week and multi-year lows and is behaving like mCopaxone is a foregone conclusion

Like all good things, Copaxone is coming to a end with the only questions being who and when.

[imnot6]

TA I can understand

Your "Uh-oh!" and "We're back in business!" annotations made me chuckle. That's pretty much my level of sophistication when it comes to analyzing trends.

Maybe add "You see that, Elizabeth? I'm coming to join ya, honey!" for the steeper, deeper declines.

[tekcor_atnm]

MNTA: TA 9/16/2011, Continues to move above resistance

MNTA continues to move above the $17.50 resistance level. Volume was above average due to quadruple witching. Ideally, I'd like to see MNTA start to accelerate out of the current channel (blue lines in chart below). Based on the technicals, I believe that there is a high likelihood of a positive event occurring in the next few weeks to cause MNTA to stay above the $17.50 level for good (and as long as the broader market continues its constructive action).

The last significant lows in January were created by TEVA's "minor deficiency". I believe that TEVA's silence and tEnox not being approved subsequently caused MNTA to recover. IMO, the recent lows were caused by the market correction. So my thinking is that a market related event (upgrades, addition to an index) might cause it to recover this time. But I don't care what the events are as long as they are positive.





The long-term chart for MNTA looks excellent. MNTA continues to move in channel area C of my chart and might be in a slightly accelerated channel. Recall that MNTA has remained above the lowest trendline on the chart for almost four years, even through the 2008 - 2009 recession and bear market. I believe that the only way it could move below that trendline is if tEnoxaparin is approved.